Sign in

Center for Pharmaceutical Policy and Prescribing

@pittcp3.bsky.social
493 followers 203 following 468 posts

Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh. Our research helps improve quality, safety, & efficiency of medication use.

PostsRepliesMedia
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 30/09/2026
New study: telemedicine bridge clinics improved buprenorphine continuity, cut ED visits 18%, lowered Medicaid spending. Co-authored by CP3's Julie Donohue. www.sciencedirect.com/science/arti... #OpioidUseDisorder #Telemedicine #Medicaid
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 17/09/2026
New study co-authored by CP3's Tim Anderson: Medicare Advantage lowers procedures, ED visits, and hospitalizations vs Traditional Medicare, but reductions are smaller for Black and Hispanic beneficiaries. jamanetwork.com/journals/jam...
011
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 14/09/2026
CP3's Julie Donohue joined JAMA Network's Healthy Dialogue podcast to unpack the Medicaid cuts in the One Big Beautiful Bill Act and what they mean for coverage and rural hospitals. jamanetwork.com/journals/jam...
jamanetwork.com
Everyone Will Feel the $1 Trillion Cut in Medicaid
Proposed Medicaid cuts in the One Big Beautiful Bill Act and how they could affect patients, clinicians, and health care organizations are discussed by Derek C. Angus, MD, MPH, and Julie Donohue, PhD,...
010
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 11/09/2026
New study co-authored by CP3's Katie Suda: a web-based decision support tool for dental antibiotic prescribing saw low uptake and no significant change in prescribing knowledge or confidence. More work is needed to drive adoption. bit.ly/4iHLpbJ
111
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 08/09/2026
CP3's Tim Anderson was featured in a NYT article on drugs older adults may overuse, including daily aspirin. Trials show little benefit for primary prevention, and bleeding risk rises with age. His advice: talk to your doctor. www.nytimes.com/2026/09/05/w...
nytimes.com
3 Common Drugs Older Adults May Be Overusing
Not all older people need these medications, and they can carry increased risks.
010
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 08/09/2026
Are you registered yet? You won't want to miss this one!
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 03/09/2026
CP3's Tim Anderson co-authored a JAMA Viewpoint on NIH's Public Access Policy requiring free access to NIH-funded research. It examines pay-to-comply publisher practices and what NIH must do next. jamanetwork.com/journals/jam... #HealthPolicy #NIH
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 01/09/2026
New trial led by CP3's Jing Luo: in youth with Type 1 diabetes in Bangladesh and Tanzania, glargine insulin cut dangerous low blood sugar by 12 months vs older insulin. www.medschool.pitt.edu/news/newer-i...
medschool.pitt.edu
Newer Insulin May Reduce Dangerous Low Blood Sugar in Youth With Type 1 Diabetes in Low-Resource Settings | School of Medicine | University of Pittsburgh
Photo credit: Jing Luo, UPMC A trial led by University of Pittsburgh researchers and published July 6 in The Lancet Diabetes & Endocrinology adds nuance to the question of whether older human insulins...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 28/08/2026
CP3's Kangho Suh co-authors study on RWE in Medicare drug price talks. www.ispor.org/publications...
010
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 27/08/2026
CP3 heads to ISPE 2026 in Milan! Faculty are presenting research projects on drug shortages, machine learning in health data, and medication safety, featuring Katie Suda, Walid Gellad, Wei-Hsuan Lo-Ciganic, Ted Park, and Timothy Anderson. #Pharmacoepidemiology #ISPE2026
030
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 27/08/2026
Most people treated for OUD in the US are on Medicaid, yet patient measures rarely inform quality improvement. New commentary on Project ELVIS links patient experience to claims measures. CP3's Julie Donohue co-authors. journals.sagepub.com/doi/10.1177/...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 26/08/2026
Attending #ISPEAnnual2026 in Milan? Consider joining the course "Practical Skills in Protocol Writing and Statistical Analytic Programming," featuring CP3's Jenny Lo-Ciganic among the course faculty.
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 26/08/2026
New CP3 brief is live. Pitt medical student Kelsey Lyons summarizes Katie Suda's team's research on drug shortages and options to build resilience. Read it: researchsites.pitt.edu/files/cp3/fi... #DrugShortages #HealthPolicy
researchsites.pitt.edu
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 26/08/2026
Medicaid covers a disproportionate share of MOUD treatment for opioid use disorder, yet gaps persist. New paper co-authored by CP3's Julie Donohue describes BHTER, a QI collaborative to boost MOUD receipt and equity in Medicaid. journals.sagepub.com/doi/10.1177/...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 25/08/2026
Welcome back Inma Hernandez, PhD, former CP3 Associate Director, now Senior Advisor for Drug Prices at CMS, for an insider look at drug pricing policy. Sept 28, in person only. Register: calendar.pitt.edu/event/inside...
020
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 25/08/2026
Only 5.7% of older adults hospitalized for a fracture went on to get medication to prevent future ones, per a new study in JGIM. CP3's Bridget Mayrer and Tim Anderson are co-authors. link.springer.com/article/10.1...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 24/08/2026
New study: Medicare's 2019 opioid limits hit rural and urban beneficiaries with disabilities differently. Rural patients saw weaker limits and lower follow-up doses, a sign of access gaps. Co-author: CP3's Bryant Shuey. www.ajpmonline.org/article/S074...
010
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 21/08/2026
New study: military exposure to inorganic dust linked to higher sarcoidosis risk in Veterans, peaking 2-5 years post-service. CP3's Walid Gellad co-authored. academic.oup.com/annalsats/ad... #Veterans #Sarcoidosis #HealthPolicy
011
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 20/08/2026
New JAMA study led by CP3's Tim Anderson: the 2026 AHA/ACC dyslipidemia guideline expands statin eligibility to 21.5M more US adults. Now 87.5M adults (56.6%) are eligible, incl. 93%+ of those aged 70-79. jamanetwork.com/journals/jam... #CardioHealth #HealthPolicy
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 13/08/2026
New in Health Affairs: opioid hospitalizations fell 2016-2023, unevenly. Hispanic, Native American, Medicaid, and older patients saw smaller drops; deaths and self-directed discharges rose. By CP3's T. Park, T. Anderson. www.healthaffairs.org/doi/10.1377/... #OpioidCrisis
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 12/08/2026
New study co-authored by CP3's Bryant Shuey: only 9.6% of U.S. adults with alcohol use disorder got treatment in 2023. Black and African American adults had the lowest treatment rates overall and across most social determinants examined. psychiatryonline.org/doi/10.1176/...
012
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 07/08/2026
New research from CP3's Kangho Suh: Black youths had lower odds of antipsychotic use before a schizophrenia diagnosis, and lower antidepressant/benzodiazepine use before an MDD diagnosis, vs White youths. Differences emerge before diagnosis. onlinelibrary.wiley.com/doi/10.1111/...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 06/08/2026
New study: VA community care eligibility not linked to more polypharmacy or risky meds in older Veterans overall. Slight uptick in high pill counts among those with mental health conditions. onlinelibrary.wiley.com/doi/10.1111/...
010
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 05/08/2026
Pitt's General Internal Medicine fellowship applications are open for July 2027 start. Deadline Sept 10. Clinician-Researcher Fellowship: dom.pitt.edu/dgim/fellows... ACES Fellowship: dom.pitt.edu/dgim/fellows...
dom.pitt.edu
Clinician-Researcher Fellowship | GIM | Department of Medicine
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 03/08/2026
Oregon Medicaid's 2016 policy capping benzodiazepine scripts at 4 weeks was linked to a substantial drop in long-term use and modest declines in overdose, self-harm, and withdrawal events. Work from Hartung's time as CP3 Visiting Scholar, with CP3's Anderson & Park. www.ovid.com/jnls/lww-med...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 31/07/2026
New @jamainternalmed.com study: 54% of new heart failure medication prescriptions went unfilled within 7 days of discharge, and only 42% of patients were adherent at 6 months. Coauthored by CP3's Tim Anderson. jamanetwork.com/journals/jam... #HeartFailure #GDMT
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 29/07/2026
New JAMA Network Open research (with CP3's Anderson) finds Medicare drug-waste spending dropped to 1.8% before the 2021 refund policy even took effect, then held flat, still costing ~$1B/year by 2023. Refund rules may be maxed out. jamanetwork.com/journals/jam...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 27/07/2026
New in Medical Care: Patience Dow (former CP3 postdoc) & Julie Donohue (CP3 faculty) find Medicaid prescription caps linked to 12% higher risk of treatment gaps for opioid use disorder meds across 37 states. Caps may undermine treatment continuity. www.ovid.com/jnls/lww-med... #HealthPolicy
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 23/07/2026
Congratulations to our faculty and friends in the University of Pittsburgh School of Pharmacy for receiving the Lawrence C. Weaver Transformative Community Service Award from the American Association of Colleges of Pharmacy (AACP)! www.pittwire.pitt.edu/accolades-ho...
pittwire.pitt.edu
Pitt’s School of Pharmacy received a national community service award
The school was honored at the American Association of Colleges of Pharmacy for its commitment to addressing unmet community needs through education, practice and research.
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 20/07/2026
CP3's Tim Anderson, in JAMA today: 87.5M U.S. adults now recommended for statins under new guidelines — 21.5M more than before. A sea change for how doctors counsel patients on CV risk. www.upmc.com/media/news/0...
upmc.com
Over Half of U.S. Adults Eligible for Statins Under New Guidelines
Recommendations for cholesterol-lowering therapy expand by 21.5 million people
020
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 20/07/2026
Congrats to CP3's Lucas Berenbrok & collaborator Elaine Mormer on their R13 grant from NIDCD to host the 2nd OTC Hearing Aid & Hearing Self-Care Symposium at Pitt — building on a decade of collaboration!
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 17/07/2026
CP3's Tim Anderson weighs in on the FDA's approval of Lipfendra, the first oral PCSK9 inhibitor, a new "tool in the toolbox" for patients who can't tolerate statins. triblive.com/news/health-...
triblive.com
New cholesterol drug could ‘transform treatment’ — but statins aren’t going anywhere, doctors say
Pittsburgh doctors on Thursday hailed government approval of a highly effective anti-cholesterol pill that had previously been available only as an injection, but they cautioned that cheap, traditiona...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 09/07/2026
🎉 New funding! BUP-CARE, led by University of Florida with Jenny Lo-Ciganic heading Pitt's CP3 team, will use ML & EHR data to predict buprenorphine discontinuation risk, helping PCPs intervene early for patients with opioid use disorder. NIDA funded. cp3.pitt.edu/BUP-CARE
cp3.pitt.edu
Developing and Evaluating a Machine-Learning Buprenorphine Care Discontinuity Prediction E-Tool (BUP-CARE)
Learn about BUP-CARE, a research study at the University of Pittsburgh's Center for Pharmaceutical Policy and Prescribing (CP3). BUP-CARE uses machine learning within electronic health records to pred...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 08/07/2026
New study in The Lancet: older adults with obesity now have BP & cholesterol near normal-weight levels, thanks to more meds. Under-40s with obesity still face higher heart risks. STAT talked to CP3's Tim Anderson: www.statnews.com/2026/07/01/l...
statnews.com
Statins and blood pressure drugs changing health risks of obesity, study suggests
New research shows obesity patients over 40 are managing blood pressure and cholesterol as well as healthy-weight peers, but younger adults remain at risk.
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 07/07/2026
CP3's Jing Luo led the first RCT comparing glargine vs. human insulin for youth with type 1 diabetes in low-resource settings. Key finding: no significant difference. 🌍 www.sciencedirect.com/science/arti...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 06/07/2026
CP3's Drs. Donohue, Gellad & Lo-Ciganic joined NIDA experts to explore target trial emulation & digital health tools for SUD research. Read the proceedings here: www.jsatjournal.com/article/S294...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 30/06/2026
New CP3 analysis (Drake & Donohue) found greater methadone/naltrexone availability raised use among White Medicaid enrollees, but not Black or Hispanic enrollees. 🔍 Access alone won't close OUD treatment gaps. More: jamanetwork.com/journals/jam... @jamahealthforum.com
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 26/06/2026
Our latest newsletter is live! We've got conference recaps, speaker highlights, a new machine learning prediction grant, new papers, and more! createsend.com/t/j-1B759B6E...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 25/06/2026
In this analysis, there were language-based disparities in orders for physical restraints & antipsychotics among hospitalized patients. More investigation is needed to explain and mitigate these differences. Read more @journalgim.bsky.social: link.springer.com/article/10.1...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 23/06/2026
🆕analysis of dental claims found 1 adverse outcome for every 27 pediatric dental sedation visits, highlighting the need for improved risk mitigation to improve safety in young dental patients. Read more: jada.ada.org/article/S000...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 22/06/2026
For adults with diabetes, the inclusion of HbA1c & UACR in the PREVENT equations is an opportunity to individualize their CVD risk estimation. Read more: www.ajpmonline.org/article/S074...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 11/06/2026
We've joined LinkedIn! Follow us for more in-depth updates on our papers, presentations, and announcements. www.linkedin.com/company/pitt...
linkedin.com
Center for Pharmaceutical Policy and Prescribing | LinkedIn
Center for Pharmaceutical Policy and Prescribing | 31 followers on LinkedIn. Center for Pharmaceutical Policy and Prescribing (CP3) at the University of Pittsburgh. | The Center for Pharmaceutical Pol...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 09/06/2026
We've learned a lot in our ten years of designing & implementing risk prediction models! We're looking forward to traveling to #cpdd26 to join our friends from @brownpublichealth.bsky.social to share what we've learned! @cpddorg.bsky.social
030
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 08/06/2026
Findings from this analysis suggest that supply chain issues alone don't translate into a shortage, highlighting a need for a better system to identify true shortages that affect patients’ ability to access medications. Read more @jamanetworkopen.com jamanetwork.com/journals/jam...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 05/06/2026
Our machine learning maven Dr. Jenny Lo-Ciganic has done it again! This time, she was part of a team that improved prediction of hepatitis C infection using natural language processing of social determinants of health-related clinical notes. www.journal-of-hepatology.eu/article/S016...
120
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 03/06/2026
Raising the ferritin cutoff to diagnose iron deficiency anemia sounds helpful, but who does it actually catch? Mostly premenopausal women who need dietary iron, not GI workups. New data from Drs. Anderson & Vajravelu: onlinelibrary.wiley.com/doi/10.1002/...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 02/06/2026
In this analysis, baseline HTN didn't influence initial analgesic choice in incident OA patients. Safer, evidence-based alternatives are needed for older adults with comorbid HTN. Read more: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 01/06/2026
With so many EHR interventions lately, alert fatigue is an important metric to consider. However, measurement methods aren't clearly or consistently defined, according to a 🆕review. Read more: academic.oup.com/jamia/advanc...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 29/05/2026
In this analysis of VHA data, 8.5% of users of a group of 29 different medications experienced disruptions related to the shortage. Ophthalmic and antipsychotic agents were more likely to experience disruption. Read more: onlinelibrary.wiley.com/doi/10.1002/...
000
Center for Pharmaceutical Policy and Prescribing @pittcp3.bsky.social · 28/05/2026
🚨Job alert!🚨 Pitt Pharmacy is hiring a tenure track position for a Professor of Pharmacogenomics/Precision Medicine. Be part of a highly productive, highly collaborative environment! More: cfopitt.taleo.net/careersectio...
cfopitt.taleo.net
Faculty.Professor.Professor - Full-Time
Click the link provided to see the complete job description.
000